Alteration of plasmalemmal caveolae mimics endothelial dysfunction observed in atheromatous rabbit aorta

Cardiovascular Research

Volumn 50, Issue 3, 2001, Pages 566-576

  Darblade, Benoît ^a   Caillaud, Dominique ^a   Poirot, Marc ^a   Fouque, Marie José ^b   Thiers, Jean Claude ^a   Rami, Jacques ^a,b   Bayard, Francis ^a   Arnal, Jean François ^a,b  

^a CHU RANGUEIL   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

Atherosclerosis; Cholesterol; Endothelial function; Nitric oxide

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; ACETYLCHOLINE; BRADYKININ; CALCIMYCIN; CHOLESTEROL; FILIPIN; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PHENYLEPHRINE;

ACETYLCHOLINE RELEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA ATHEROSCLEROSIS; AORTA INTIMA; ARTERY CONSTRICTION; ARTICLE; CALCIUM CELL LEVEL; CELL FUNCTION; CELL STRUCTURE; CONTROLLED STUDY; ENDOTHELIUM; HYPERCHOLESTEROLEMIA; LIPID STORAGE; MEMBRANE STRUCTURE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RABBIT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE RELAXATION;

ANIMALS; AORTA, THORACIC; AORTIC DISEASES; ARTERIOSCLEROSIS; BETA-CYCLODEXTRINS; CELL CULTURE TECHNIQUES; CELL MEMBRANE; CYCLODEXTRINS; ENDOTHELIUM, VASCULAR; FILIPIN; HYPERCHOLESTEROLEMIA; MALE; MICROSCOPY, ELECTRON; MUSCLE CONTRACTION; NITRIC OXIDE; RABBITS;

EID: 0034999516     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(01)00251-6     Document Type: Article

References (44)

1. Furchgott R.F., Zawadski J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature (London). 228:1980;373-376.
2. Ignarro L.J. Endothelium-derived nitric oxide: actions and properties. FASEB J. 3:1989;31-36.
3. Moncada S., Higgs A. The L-arginine-nitric oxide pathway. New Engl J Med. 329:1993;2002-2012.
4. Griffith O.W., Stuehr D.J. Nitric oxide synthases: properties and catalytic mechanism. Annu Rev Physiol. 57:1995;707-736.
5. 2+- calmodulin and caveolin. J Biol Chem. 272:1997;15583-15586.
6. Feron O., Belhassen L., Kobzik L., Smith T.W., Kelly R.A., Michel T. Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells. J Biol Chem. 271:1996;22810-22814.
7. Michel T., Feron O. Nitric oxide synthases: which, where, how, and why? J Clin Invest. 100:1997;2146-2152.
8. Anderson R.G. The caveolae membrane system. Annu Rev Biochem. 67:1998;199-225.
9. Liu J., Schnitzer J.E. Analysis of lipids in caveolae. Methods Mol Biol. 116:1999;61-72.
10. Smart E.J., Graf G.A., McNiven M.A., et al. Caveolins, liquid-ordered domains, and signal transduction. Mol Cell Biol. 19:1999;7289-7304.
11. Harrison D.G. Cellular and molecular mechanisms of endothelial cell dysfunction. J Clin Invest. 100:1997;2153-2157.
12. Smart E.J., Ying Y.S., Conrad P.A., Anderson R.G. Caveolin moves from caveolae to the Golgi apparatus in response to cholesterol oxidation. J Cell Biol. 127:1994;1185-1197.
13. Neufeld E.B., Cooney A.M., Pitha J., et al. Intracellular trafficking of cholesterol monitored with a cyclodextrin. J Biol Chem. 271:1996;21604-21613.
14. Furuchi T., Anderson R.G. Cholesterol depletion of caveolae causes hyperactivation of extracellular signal-related kinase (ERK). J Biol Chem. 273:1998;21099-21104.
15. Schnitzer J.E., Oh P., Pinney E., Allard J. Filipin-sensitive caveolae-mediated transport in endothelium: reduced transcytosis, scavenger endocytosis, and capillary permeability of select macromolecules. J Cell Biol. 127:1994;1217-1232.
16. Kilsdonk E.P., Yancey P.G., Stoudt G.W., et al. Cellular cholesterol efflux mediated by cyclodextrins. J Biol Chem. 270:1995;17250-17256.
17. Bolard J. How do the polyene macrolide antibiotics affect the cellular membrane properties? Biochim Biophys Acta. 864:1986;257-304.
18. Blair A., Shaul P.W., Yuhanna I.S., Conrad P.A., Smart E.J. Oxidized low density lipoprotein displaces endothelial nitric-oxide synthase (eNOS) from plasmalemmal caveolae and impairs eNOS activation. J Biol Chem. 274:1999;32512-32519.
19. Siedel J., Hagele E.O., Ziegenhorn J., Wahlefeld A.W. Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem. 29:1983;1075-1080.
20. Nascimento C.A., Kauser K., Rubanyi G.M. Effect of 17beta-estradiol in hypercholesterolemic rabbits with severe endothelial dysfunction. Am J Physiol. 276:1999;H1788-H1794.
21. Verbeuren T.J., Jordaens F.H., Zonnekeyn L.L., Van Hove C.E., Coene M.C., Herman A.G. Effect of hypercholesterolemia on vascular reactivity in the rabbit. I. Endothelium-dependent and endothelium-independent contractions and relaxations in isolated arteries of control and hypercholesterolemic rabbits. Circ Res. 58:1986;552-564.
22. Gospodarowicz D., Moran J., Braun D., Birdwell C. Clonal growth of bovine vascular endothelial cells: fibroblast growth factor as a survival agent. Proc Natl Acad Sci USA. 73:1976;4120-4124.
23. Arnal J.F., Clamens S., Pechet C., et al. Ethinylestradiol does not enhance the expression of nitric oxide synthase in bovine aortic endothelial cells but increases the release of bioactive nitric oxide by inhibiting superoxide anion production. Proc Natl Acad Sci USA. 93:1996;4108-4113.
24. Ishii K., Sheng H., Warner T.D., Forstermann U., Murad F. A simple and sensitive bioassay method for detection of EDRF with RFL-6 rat lung fibroblasts. Am J Physiol. 261:1991;H598-H603. (Heart Circ Physiol 30).
25. Bascands J.L., Pecher C., Rouaud S., et al. Evidence for existence of two distinct bradykinin receptors on rat mesangial cells. Am J Physiol. 264:1993;F548-F556.
26. Folch J., Lees M., Stanley H.S. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem. 226:1957;497-509.
27. Park H., Go Y.M., St John P.L., et al. Plasma membrane cholesterol is a key molecule in shear stress-dependent activation of extracellular signal-regulated kinase. J Biol Chem. 273:1998;32304-32311.
28. Rothberg K.G., Heuser J.E., Donzell W.C., Ying Y.S., Glenney J.R., Anderson R.G. Caveolin, a protein component of caveolae membrane coats. Cell. 68:1992;673-682.
29. Bossaller C., Habib G.B., Yamamoto H., Williams C., Wells S., Henry P.D. Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine 5′-monophosphate formation in atherosclerotic human coronary artery and rabbit aorta. J Clin Invest. 79:1987;170-174.
30. Verbeuren T.J., Coene M.C., Jordaens F.H., Van Hove C.E., Zonnekeyn L.L., Herman A.G. Effect of hypercholesterolemia on vascular reactivity in the rabbit. II. Influence of treatment with dipyridamole on endothelium-dependent and endothelium-independent responses in isolated aortas of control and hypercholesterolemic rabbits. Circ Res. 59:1986;496-504.
31. Bonthu S., Heistad D.D., Chappell D.A., Lamping K.G., Faraci F.M. Atherosclerosis, vascular remodeling, and impairment of endothelium-dependent relaxation in genetically altered hyperlipidemic mice. Arterioscler Thromb Vasc Biol. 17:1997;2333-2340.
32. Kessler P., Bauersachs J., Busse R., Schini-Kerth V.B. Inhibition of inducible nitric oxide synthase restores endothelium-dependent relaxations in proinflammatory mediator-induced blood vessels. Arterioscler Thromb Vasc Biol. 17:1997;1746-1755.
33. Yokoyama M., Hirata K., Miyake R., Akita H., Ishikawa Y., Fukuzaki H. Lysophosphatidylcholine: essential role in the inhibition of endothelium-dependent vasorelaxation by oxidized low density lipoprotein. Biochem Biophys Res Commun. 168:1990;301-308.
34. Kugiyama K., Kerns S.A., Morrisett J.D., Roberts R., Henry P.D. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature. 344:1990;160-162.
35. Tanner F.C., Noll G., Boulanger C.M., Luscher T.F. Oxidized low density lipoproteins inhibit relaxations of porcine coronary arteries. Role of scavenger receptor and endothelium-derived nitric oxide. Circulation. 83:1991;2012-2020.
36. Plane F., Bruckdorfer K.R., Kerr P., Steuer A., Jacobs M. Oxidative modification of low-density lipoproteins and the inhibition of relaxations mediated by endothelium-derived nitric oxide in rabbit aorta. Br J Pharmacol. 105:1992;216-222.
37. Hirata K., Akita H., Yokoyama M. Oxidized low density lipoprotein inhibits bradykinin-induced phosphoinositide hydrolysis in cultured bovine aortic endothelial cells. FEBS Lett. 287:1991;181-184.
38. Inoue N., Hirata K., Yamada M., et al. Lysophosphatidylcholine inhibits bradykinin-induced phosphoinositide hydrolysis and calcium transients in cultured bovine aortic endothelial cells. Circ Res. 71:1992;1410-1421.
39. Kugiyama K., Ohgushi M., Sugiyama S., et al. Lysophosphatidylcholine inhibits surface receptor-mediated intracellular signals in endothelial cells by a pathway involving protein kinase C activation. Circ Res. 71:1992;1422-1428.
40. Sage S.O., Adams D.J., van Breemen C. Synchronized oscillations in cytoplasmic free calcium concentration in confluent bradykinin-stimulated bovine pulmonary artery endothelial cell monolayers. J Biol Chem. 264:1989;6-9.
41. Tracey W.R., Peach M.J. Differential muscarinic receptor mRNA expression by freshly isolated and cultured bovine aortic endothelial cells. Circ Res. 70:1992;234-240.
42. Schilling W.P., Rajan L., Strobl-Jager E. Characterization of the bradykinin-stimulated calcium influx pathway of cultured vascular endothelial cells. Saturability, selectivity, and kinetics. J Biol Chem. 264:1989;12838-12848.
43. Gimpl G., Burger K., Fahrenholz F. Cholesterol as modulator of receptor function. Biochemistry. 36:1997;10959-10974.
44. Pike L.J., Miller J.M. Cholesterol depletion delocalizes phosphatidylinositol bisphosphate and inhibits hormone-stimulated phosphatidylinositol turnover. J Biol Chem. 273:1998;22298-22304.